These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28693282)

  • 1. Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis.
    Zhang DQ; Zhou CK; Chen SZ; Yang Y; Shi BK
    Oncol Lett; 2017 Jul; 14(1):1115-1122. PubMed ID: 28693282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy.
    Liu J; Hua P; Hui L; Zhang LL; Hu Z; Zhu YW
    Exp Ther Med; 2016 Oct; 12(4):2109-2119. PubMed ID: 27703495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes and pathways associated with retinoblastoma based on co-expression network analysis.
    Wang QL; Chen X; Zhang MH; Shen QH; Qin ZM
    Genet Mol Res; 2015 Dec; 14(4):16151-61. PubMed ID: 26662407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
    Bi D; Ning H; Liu S; Que X; Ding K
    Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pathway-related modules in high-grade osteosarcoma based on topological centrality of network strategy.
    Ning B; Xu DL; Gao JH; Wang LL; Yan SY; Cheng S
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2209-20. PubMed ID: 27338044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network spatio-temporal analysis predicts disease stage-related genes and pathways in renal cell carcinoma.
    Li1 XH; Yang CZ; Wang J
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study.
    Liu N; Zhang GD; Bai P; Su L; Tian H; He M
    World J Clin Oncol; 2022 Aug; 13(8):675-688. PubMed ID: 36160462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes and pathways in bladder cancer using bioinformatics analysis.
    Li D; Zhen F; Le J; Chen G; Zhu J
    Am J Clin Exp Urol; 2022; 10(1):13-24. PubMed ID: 35291419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes and pathways for esophageal squamous cell carcinoma by bioinformatics analysis.
    Chen X; Cai S; Li B; Zhang X; Li W; Linag H; Cao X
    Exp Ther Med; 2018 Aug; 16(2):1121-1130. PubMed ID: 30112053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and identification of key biomarkers in bladder carcinoma: Evidence from bioinformatics analysis.
    Yan M; Jing X; Liu Y; Cui X
    Oncol Lett; 2018 Sep; 16(3):3092-3100. PubMed ID: 30127900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.
    Li S; Liu X; Liu T; Meng X; Yin X; Fang C; Huang D; Cao Y; Weng H; Zeng X; Wang X
    Front Physiol; 2017; 8():947. PubMed ID: 29234286
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of differentially expressed genes in white blood cells isolated from patients with major burn injuries.
    Tang G; Zhang T; Wang X; Song Z; Liu F; Zhang Q; Huo R
    Exp Ther Med; 2017 Oct; 14(4):2931-2936. PubMed ID: 28966676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
    Xu L; Tong T; Wang Z; Qiang Y; Ma F; Ma X
    Am J Med Sci; 2020 Apr; 359(4):226-234. PubMed ID: 32200915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
    Deng L; Gu X; Zeng T; Xu F; Dong Z; Liu C; Chao H
    Oncol Lett; 2019 Sep; 18(3):3236-3248. PubMed ID: 31452801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes in peripheral blood mononuclear cells for the diagnosis of hepatocellular carcinoma using a weighted gene co-expression network analysis.
    Ye Z; Zeng Z; Shen Y; Chen Z
    Exp Ther Med; 2020 Aug; 20(2):890-900. PubMed ID: 32742331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
    Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
    J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.